Send to a Friend Share

Allergan (AGN) Shifts President Role

March 8, 2011 6:55 AM EST
Allergan, Inc. (NYSE: AGN) announced the following management changes:
  • David E.I. Pyott to President; and

  • F. Michael Hall will be leaving the company to join Hospira (NYSE: HSP) as CEO.
Pyott’s role as President will be effective March 27, 2011.


Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In


Related Categories

Management Changes

Add Your Comment





Follow StreetInsider.com On Twitter